XRAY — STK Cmn

Ownership history in CITADEL ADVISORS LLC  ·  135 quarters on record

AI Ownership Summary

CITADEL ADVISORS LLC reported STK Cmn (XRAY) in 135 quarterly 13F filings from 2023 Q4 through 2025 Q4. Peak portfolio weight reached 0.03% in 2023 Q4. The latest visible filing shows XRAY at 0.00% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this XRAY ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was CITADEL ADVISORS LLC's position in STK Cmn, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2025 Q4

XRAY was reported at 0.00% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.03% in 2023 Q4

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q4 to 2025 Q4

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

XRAY stock page CITADEL ADVISORS LLC fund profile CITADEL ADVISORS LLC full holdings
How CITADEL ADVISORS LLC held XRAY — position size vs. price
% of Fund (quarterly)    XRAY price (quarter-end, indexed to 100)
📋 Quarterly Holdings History 26 quarters  ▾
Quarter Action Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2025 Q4 REDUCED 173,400 -1,556,247 -90.0% 0.00% $2.0M 2026-02-14 (Est.) $12.95
2025 Q4 ADDED 1,729,647 +1,707,347 +7656.3% 0.00% $19.8M 2026-02-14 (Est.) $12.95
2025 Q3 REDUCED 22,300 -103,000 -82.2% 0.00% $283K 2025-11-14 $10.37
2025 Q3 REDUCED 125,300 -948,443 -88.3% 0.00% $1.6M 2025-11-14 $10.37
2025 Q3 ADDED 1,073,743 +1,052,043 +4848.1% 0.00% $13.6M 2025-11-14 $10.37
2025 Q2 REDUCED 21,700 -46,300 -68.1% 0.00% $345K 2025-08-14 $13.50
2025 Q2 REDUCED 68,000 -286,738 -80.8% 0.00% $1.1M 2025-08-14 $13.50
2025 Q2 REDUCED 354,738 -1,058,248 -74.9% 0.00% $5.6M 2025-08-14 $13.50
2025 Q1 ADDED 1,412,986 +1,034,886 +273.7% 0.00% $21.1M 2025-05-15 $15.89
2025 Q1 ADDED 378,100 +323,500 +592.5% 0.00% $5.6M 2025-05-15 $15.89
2025 Q1 REDUCED 54,600 -1,631,217 -96.8% 0.00% $816K 2025-05-15 $15.89
2024 Q4 ADDED 1,685,817 +1,485,017 +739.6% 0.01% $32.0M 2025-02-14 $17.47
2024 Q4 REDUCED 200,800 -226,700 -53.0% 0.00% $3.8M 2025-02-14 $17.47
2024 Q4 ADDED 427,500 +86,400 +25.3% 0.00% $8.1M 2025-02-14 $17.47
2024 Q3 ADDED 341,100 +110,500 +47.9% 0.00% $9.2M 2024-11-14 $16.90
2024 Q3 REDUCED 230,600 -1,013,884 -81.5% 0.00% $6.2M 2024-11-14 $16.90
2024 Q3 ADDED 1,244,484 +644,640 +107.5% 0.01% $33.7M 2024-11-14 $16.90
2024 Q2 ADDED 599,844 +583,444 +3557.6% 0.00% $14.9M 2024-08-14 $23.24
2024 Q2 REDUCED 16,400 -49,700 -75.2% 0.00% $409K 2024-08-14 $23.24
2024 Q2 REDUCED 66,100 -884,428 -93.0% 0.00% $1.6M 2024-08-14 $23.24
2024 Q1 ADDED 950,528 +945,828 +20124.0% 0.01% $31.5M 2024-05-15 $26.39
2024 Q1 REDUCED 4,700 -31,700 -87.1% 0.00% $156K 2024-05-15 $26.39
2024 Q1 ADDED 36,400 +19,100 +110.4% 0.00% $1.2M 2024-05-15 $26.39
2023 Q4 REDUCED 17,300 -6,700 -27.9% 0.00% $616K 2024-02-14 $30.36
2023 Q4 REDUCED 24,000 -3,553,993 -99.3% 0.00% $854K 2024-02-14 $30.36
2023 Q4 ADDED 3,577,993 +3,560,893 +20823.9% 0.03% $127.3M 2024-02-14 $30.36
109 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

🏢 Other funds also holding XRAY

As of 2025 Q4 — sorted by position size

Brickwood Asset Management LLP 23.8% QVIDTVM Management LLC 3Y 6.28% Invenomic Capital Management LP 3Y 2.73% CONTINENTAL ADVISORS LLC 3Y 7Y 2.52% New Century Financial Group, LLC 1.93% SKBA CAPITAL MANAGEMENT LLC 3Y 7Y 1.87% CONTINENTAL ADVISORS LLC 3Y 7Y 1.55% Villanova Investment Management Co LLC 1.23% PARADIGM CAPITAL MANAGEMENT INC/NY 3Y 7Y 1.15% COOKE & BIELER LP 3Y 7Y 1.01%

FAQ About CITADEL ADVISORS LLC and XRAY

These are the practical questions this page is built to answer before you even open the full history table.

How long has CITADEL ADVISORS LLC reported owning XRAY?

CITADEL ADVISORS LLC reported XRAY across 26 quarterly 13F filings, from 2023 Q4 through 2025 Q4.

What was the largest reported XRAY position in CITADEL ADVISORS LLC's portfolio?

The largest reported portfolio weight for XRAY was 0.03% in 2023 Q4.

What is the latest reported XRAY position on this page?

The most recent filing on this page is 2025 Q4, when CITADEL ADVISORS LLC reported 173,400 shares, equal to 0.00% of portfolio, with an estimated market value of $2.0M.

What does the chart on this XRAY ownership page compare?

The chart compares CITADEL ADVISORS LLC's quarterly XRAY portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

← Back to CITADEL ADVISORS LLC Holdings